CONSULTANTS RESPONSIBLE FOR THE PROGRAM:

1- Dr. Mohamed Mahmoud AbdElhakim
Consultant of radiotherapy at Shefa El Orman
- Specialization - Curriculum vitae

2- Dr. Emad shash
Consultant of medical oncology at Shefa El Orman
- Specialization - Curriculum vitae

3- Dr. Tarek M Hashem
Consultant of surgical oncology at Shefa El Orman
- Specialization - Curriculum vitae

4- Dr. Mohamed Adly El Ramely
Consultant of anesthesiology at Shefa El Orman
- Specialization - Curriculum vitae

Information for the patients:

- Breast cancer is a disease in which abnormal breast cells grow out of control and form a mass called a tumor. The tumor can grow to invade and destroy healthy body tissue. In time, cancer cells can break away and spread to other parts of the body. When cancer spreads, it's called metastatic cancer.

Incidence

- Breast cancer is the most common cancer diagnosed in women.
- Approximately 99% of breast cancers occur in women and 0.5–1% of breast cancers occur in men.
- Breast cancer survival rates have been increasing. Much of this is due to the widespread support for breast cancer awareness.
- Advances in breast cancer screening allow healthcare professionals to diagnose breast cancer earlier. Finding the cancer earlier makes it much more likely that the cancer can be cured.

CONSULTANTS RESPONSIBLE FOR THE PROGRAM:
1- Dr. Ayman Abdel Wahab Amin
Consultant of gastro enterology surgery at Shefa El Orman
- Specialization - Curriculum vitae
2- Dr. Mohamed Mahmoud AbdElhakim
Consultant of radiotherapy at Shefa El Orman
- Specialization - Curriculum vitae
3- Dr. Noha Rashad
Consultant of medical oncology at Shefa El Orman
- Specialization - Curriculum vitae
4- Dr. Mohamed Adly El Ramely
Consultant of anesthesiology at Shefa El Orman
- Specialization - Curriculum vitae
5- Dr. Shady El Sebaey
Consultant of intervention radiology at Shefa El Orman
- Specialization - Curriculum vitae
 

CONSULTANTS RESPONSIBLE FOR THE PROGRAM:
1- Dr. Ziyad Samir Sayed
Consultant of gynecological surgery at Shefa El Orman
- Specialization - Curriculum vitae
2- Dr. Mohamed Mahmoud AbdElhakim
Consultant of radiotherapy at Shefa El Orman
- Specialization - Curriculum vitae
3- Dr. Mariam Hussin
Consultant of clinical oncology at Shefa El Orman
- Specialization - Curriculum vitae
4- Dr. Mohamed Adly El Ramely
Consultant of anesthesiology at Shefa El Orman
Specialization - Curriculum vitae
 

CONSULTANTS RESPONSIBLE FOR THE PROGRAM:
5- Dr. Mohamed Mahmoud AbdElhakim
Consultant of radiotherapy at Shefa El Orman
- Specialization - Curriculum vitae
6- Dr. Osama Abdel Mohaimen
Consultant of medical oncology and hematology at Shefa El Orman
- Specialization - Curriculum vitae

 

CONSULTANTS RESPONSIBLE FOR THE PROGRAM:
1- Dr. Ayman Abdel Wahab Amin
Consultant of head and neck surgery at Shefa El Orman
- Specialization - Curriculum vitae
2- Dr. Mohamed Mahmoud AbdElhakim
Consultant of radiotherapy at Shefa El Orman
- Specialization - Curriculum vitae
3- Dr. Mariam Hussin
Consultant of clinical oncology at Shefa El Orman
- Specialization - Curriculum vitae
4- Dr. Mohamed Adly El Ramely
Consultant of anesthesiology at Shefa El Orman
- Specialization - Curriculum vitae
 

CONSULTANTS RESPONSIBLE FOR THE PROGRAM:
9- Dr. Shady El Sebaey

Consultant of intervention radiology at Shefa El Orman
- Specialization - Curriculum vitae

10- Dr. Mohamed Adly El Ramely
Consultant of anesthesiology at Shefa El Orman
- Specialization - Curriculum vitae
 

Including:

• Chemoembolization and embolization using microcatheter, microspheres and beads.
• All guided biopsy procedures (CT or ultrasound guided).
• Insertion of all types of draining catheters like (percutaneous nephrostomy, percutaneous biliary drainage).
• Percutaneous stent insertion.
• Percutaneous Radio frequency ablation.
• Percutaneous microwave ablation.
• Occlusion of artery with coils.

CONSULTANTS RESPONSIBLE FOR THE PROGRAM:
1- Dr. Galal Rafik Galy
Consultant of thoracic surgery at Shefa El Orman
- Specialization - Curriculum vitae

2- Dr. Amr Mahmoud El Demery
Consultant of thoracic surgery at Shefa El Orman
- Specialization - Curriculum vitae

3- Dr. Mohamed Mahmoud AbdElhakim
Consultant of radiotherapy at Shefa El Orman
- Specialization - Curriculum vitae

4- Dr. Maha Yahia
Consultant of medical oncology at Shefa El Orman
- Specialization - Curriculum vitae

5- Dr. Mohamed Adly El Ramely
Consultant of anesthesiology at Shefa El Orman
- Specialization - Curriculum vitae

6- Dr. Shady El Sebaey
Consultant of intervention radiology at Shefa El Orman
- Specialization - Curriculum vitae

Information for the patients: Lung cancer begins when epithelial cells, which form the inside lining of the lungs, grow rapidly and uncontrollably. Often, these cells develop into a mass called a tumor. A malignant or cancerous tumor can stay in one place or spread to other parts of the body. Early lung cancer often has no symptoms and can only be detected by medical imaging. As the cancer progresses, most people experience nonspecific respiratory problems: coughing, shortness of breath, or chest pain. Other symptoms depend on the location and size of the tumor. Incidence: • Lung cancer is the third most common cancer type worldwide.
• The average age of diagnosis is 65-70 years old.
• Men are twice as likely to be diagnosed with lung cancer, which largely reflects differences in tobacco consumption.
• Lung cancer is the leading cause of cancer-related deaths worldwide, accounting for the highest mortality rates among both men and women.
• Smoking is the leading cause of lung cancer, responsible for approximately 85% of all cases.

CONSULTANTS RESPONSIBLE FOR THE PROGRAM:

11- Dr. Mohamed Ahmed Ebrahim
Consultant of sarcoma surgery at Shefa El Orman
- Specialization - Curriculum vitae

12- Dr. Mohamed Mahmoud AbdElhakim
Consultant of radiotherapy at Shefa El Orman
- Specialization - Curriculum vitae

13- Dr. Maha Yahia
Consultant of medical oncology at Shefa El Orman
- Specialization - Curriculum vitae

14- Dr. Mohamed Adly El Ramely
Consultant of anesthesiology at Shefa El Orman
- Specialization - Curriculum vitae
 

CONSULTANTS RESPONSIBLE FOR THE PROGRAM:

15- Dr. Ahmed Abdel Bary
Consultant of urology surgery at Shefa El Orman
- Specialization - Curriculum vitae

16- Dr. Mohamed Mahmoud AbdElhakim
Consultant of radiotherapy at Shefa El Orman
- Specialization - Curriculum vitae

17- Dr. Mariam Hussin
Consultant of clinical oncology at Shefa El Orman
- Specialization - Curriculum vitae

18- Dr. Mohamed Adly El Ramely
Consultant of anesthesiology at Shefa El Orman
- Specialization - Curriculum vitae
 

Glioblastoma multiforme Brain cancer is a malignant tumor of the cells of the brain (this implies the primary occurrence of a tumor in the brain and not cancer that has metastasized to the brain from other organs). In brain cancer, normal brain cells transform into cancerous ones. In a healthy body, cells appear in the right amount and die off at a certain time, giving the space for the new ones. Cancer cells begin to grow uncontrollably, without dying off. Their accumulation forms a brain tumor. Gliomas are the most common types of brain tumors. There are 4 degrees of malignancy of such formations, based on the type of cells of the nervous tissue. Glioblastoma is the most malignant type of brain tumor, characterized by the highest rate of growth and the absence of distinguishable borders. Thus, glioblastoma belongs to brain tumors of the highest degree of malignancy, which represent the greatest difficulties for medical science in the matter of treatment. The exact causes of brain cancer have not been established. It may be associated with a hereditary predisposition, as well as with the impact of dangerous working conditions.

- Symptoms:
The main warning signs for brain tumors are: • Frequent nausea and vomiting
• Headache in the morning or headache that goes away after vomiting
• Visual impairment, hearing impairment, problems with speech
• Loss of balance and unstable gait
• The weakness of one side of the body
• Unusual sleepiness or changes in daily activity levels
• Radical changes in personality or behavior
- Diagnosis:
When carrying out computed tomography, a layered image of brain tissue is obtained. Thus, CT allows assessing the size of brain tumors and the exact location of the neoplasms. MRI is a more detailed visualization of brain tissue, in which even the smallest changes in the anatomical structure of the brain are visible. Using functional magnetic resonance imaging, the doctor evaluates blood circulation in the brain tumors and brain tissues. Magnetic resonance spectroscopy is a research technique in which the metabolism in the tissues of brain tumors is investigated. Magnetic resonance angiography reflects the relationship between the brain tumor and large arterial and venous vessels.
Treatment:
Currently, there are three types of treatment for glioblastoma beyond stage one-three. These types are surgery, radiation therapy, and chemotherapy. At the present stage, progress has been made in each of the types of treatments, but their combination gives the best results.
• Surgery.
With the information on the exact localization of the brain tumor based on MRI results, the neurosurgeon can remove a tumor without subsequent side effects. In some cases, when the brain tumor is located close to the motor or speech centers, the surgery is performed under local anesthesia, which allows patients to be conscious and allows doctors to control the speech function. After the removal of glioma, most patients have an improvement in neurological symptoms. Postoperative mortality, even for glioblastoma, reaches 1%, and the worsening of the condition is seen in up to 5% of cases. The best results are achieved after radical resection (compared to partial tumor resection or biopsy). The development of innovative methods of diagnosis and treatments allows the surgeon to successfully perform the radical removal of glioblastomas in most cases of brain tumors of such types. If the tumor is located close to the functionally important cortical structures, the surgeon should consider performing functional MRI before surgery. Using stereotactic navigation and intraoperative monitoring, an attempt should be made to remove the entire brain tumor. Time spent on carefully performed resection will be rewarded with increased survival and quality of life for patients. If the brain tumor cannot be removed, a stereotactic biopsy should be performed. Patients with a metastasized type of brain cancer should receive radiation therapy followed by chemotherapy. If the disease recurs, resection of the tumor should be considered, followed by second-line chemotherapy, experimental therapy, or participation in the clinical trials.
• Radiation therapy.
Brain tumors often recur in their previous area. That is why total radiation therapy is often performed after the surgery in order to prevent the relapse. Another type of irradiation, the localized radiation therapy, is aimed precisely at tumor cells in the brain. The development of neuroimaging techniques allows the radiologist to reduce the complications of radiation therapy by targeting the brain tumor without affecting the healthy brain structures. Therefore, it is better to use both local radiation therapy and total radiation therapy for the whole brain. Even with these precautions, delayed damage to healthy brain tissue remains a significant long-term problem. At the present stage, stereotactic surgery is the most effective and safe method to treat brain tumors. This method can be considered an alternative to the traditional surgery. This allows a large dose of radiation to be delivered to the brain tumor without an additional radiation load on healthy tissues. Modern computer technologies in imaging make it possible to carry out this type of surgery accurately. None of the currently existing surgical systems can excise the brain tumor with the same precision. The effect of radiation therapy for glioblastoma can be assessed only in several months after the procedure. The tumor is not destroyed, but it stops growing and decreases in size. Stereotactic surgery is applied in the treatment of small brain tumors that do not exceed three centimeters in diameter and have clear boundaries. Stereotactic surgery is not suitable for rapidly growing brain tumors.
• Chemotherapy.
Cane be used in combination with radiotherapy and In the stage 4 glioblastoma treatment, chemotherapy should be considered the optimal treatment, since these tumors penetrate deep into the normal brain and tumor cells are often found at a distance of up to four centimeters from the primary focus. Chemotherapy drugs cross the blood-brain barrier and can reach every tumor cell in the central nervous system. Glioblastomas are heterogeneous. Genetic and biochemical abnormalities that have been identified in glioblastomas generally only occur in certain cells. Not all glioblastoma cells have the same histochemical features, and this must be considered when choosing the treatment of glioblastoma multiforme grade 4